Department of Anesthesiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, 214023 Wuxi, Jiangsu, China.
Department of Emergency, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, 214023 Wuxi, Jiangsu, China.
Discov Med. 2024 Jul;36(186):1453-1463. doi: 10.24976/Discov.Med.202436186.135.
Levosimendan (Levo) is a drug commonly used to treat heart failure. Recent studies have suggested that Levo may have neuroprotective effects, but it is still unknown how exactly it contributes to hypoxia-induced brain damage. Thus, the aim of this study was to investigate how Levo affects hypoxia-induced brain damage and to clarify any possible underlying mechanisms.
One group of rats (Levo group) was pretreated with Levo via oral force-feeding for four weeks. Another group (Ferrostatin-1 (Fer-1) group) was pretreated with intraperitoneal injections of Fer-1 for four weeks. A rat model of chronic hypoxia was created by treating rats with 13% O for 14 days in a closed hypoxia chamber. For each group (Control, Model, Levo, Fer-1), we evaluated learning and memory capacity and the morphology and structure of neurons in the rats' brain tissue. Other measurements included tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6); malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px); Fe; apoptosis; cleaved caspase-3, caspase-3; phosphatase and tensin homolog (PTEN), protein kinase B (Akt), phosphorylated Akt (p-Akt); and ferroptosis-related proteins Nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11).
The Model group rats had considerably fewer neurons than the Control group, with loosely arranged cells, and markedly impaired learning and memory abilities ( < 0.05). Oxidative damage and inflammation in brain tissues of the Model group were significantly intensified, accompanied by a substantial increase in neuronal apoptosis ( < 0.05). PTEN protein, Fe concentration, and cleaved caspase-3 expression were all significantly upregulated, whereas p-Akt, Nrf2, GPX4, and SLC7A11 proteins were dramatically downregulated ( < 0.05). Both the Levo and Fer-1 groups demonstrated significantly more neurons and closely arranged cells than the Model group, along with a notable improvement in learning and memory abilities ( < 0.05). Oxidative damage and inflammation in brain tissues of the Levo and Fer-1 groups were markedly alleviated, and neuronal apoptosis was suppressed ( < 0.05). p-Akt, Nrf2, GPX4, and SLC7A11 proteins were dramatically upregulated, whereas the expression of cleaved caspase-3, PTEN protein, and Fe content was considerably downregulated ( < 0.05).
Levo effectively mitigates brain injury in rats with chronic hypoxia, likely by regulating ferroptosis via the PTEN/Akt signaling pathway.
左西孟旦(Levo)是一种常用于治疗心力衰竭的药物。最近的研究表明,Levo 可能具有神经保护作用,但它究竟如何有助于缺氧引起的脑损伤仍不清楚。因此,本研究旨在探讨 Levo 如何影响缺氧引起的脑损伤,并阐明任何可能的潜在机制。
一组大鼠(Levo 组)通过口服强制喂养 Levo 预处理四周。另一组(Ferrostatin-1(Fer-1)组)通过腹腔注射 Fer-1 预处理四周。通过在封闭的缺氧室中用 13% O 处理大鼠 14 天来建立慢性缺氧大鼠模型。对于每组(对照组、模型组、Levo 组、Fer-1 组),我们评估了大鼠的学习和记忆能力以及脑组织中神经元的形态和结构。其他测量包括肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6);丙二醛(MDA)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px);Fe;细胞凋亡;半胱氨酸天冬氨酸蛋白酶-3(caspase-3)、磷酸化半胱氨酸天冬氨酸蛋白酶-3(p-Akt);和铁死亡相关蛋白核因子红细胞 2 相关因子 2(Nrf2)、谷胱甘肽过氧化物酶 4(GPX4)和溶质载体家族 7 成员 11(SLC7A11)。
模型组大鼠的神经元数量明显少于对照组,细胞排列松散,学习和记忆能力明显受损(<0.05)。脑组织中的氧化损伤和炎症明显加剧,神经元凋亡显著增加(<0.05)。PTEN 蛋白、Fe 浓度和 cleaved caspase-3 表达均显著上调,而 p-Akt、Nrf2、GPX4 和 SLC7A11 蛋白则显著下调(<0.05)。Levo 和 Fer-1 组的神经元数量明显多于模型组,细胞排列紧密,学习和记忆能力明显提高(<0.05)。Levo 和 Fer-1 组脑组织的氧化损伤和炎症明显减轻,神经元凋亡受到抑制(<0.05)。p-Akt、Nrf2、GPX4 和 SLC7A11 蛋白显著上调,而 cleaved caspase-3、PTEN 蛋白和 Fe 含量的表达则显著下调(<0.05)。
Levo 通过调节 PTEN/Akt 信号通路有效减轻慢性缺氧大鼠的脑损伤。